Lirafugratinib; RLY-4008

Ainm Cheimiceach:

N-[4-(4-aimín-5-{3-fluara-4-[(4-meitilpirimidin-2-il)ocsa]feinil}-7-meitil-7H-pioróil[2,3-d]pirimidin- 6-il)feanil]-2-meitilpróp-2-éinil

Cód Smiles:

C=C(C)C(NC1=CC=C(C2=C(C3=CC=C(OC4=NC=CC(C)=N4)C(F)=C3)C5=C(N)N= CN=C5N2C)C=C1)=O

Cód InChi:

InChI=1S/C28H24FN7O2/c1-15(2)27(37)35-19-8-5-17(6-9-19)24-22(23-25(30)32-14-33-26( 23) 36(24 )4)18-7-10-21(20(29)13-18)38-28-31-12-11-16(3)34-28/h5-14H,1H2,2-4H3,(H, 35,37)(H2,30,32,33)

Eochair InChi:

XOQVZSSDIQQUGO-UHFFFAOYSA-N

Eochairfhocal:

2549174-42-5 ；CAS: 2549174-42-5 ； CAS: 2549174-42-5 ； Lirafugratinib; RLY-4008; RLY 4008; RLY4008

Tuaslagthacht: 

Stóráil:Tirim, dorcha agus ag 0 - 4 C go gearrthéarmach (laethanta go seachtainí) nó -20 C go fadtéarmach (mí go blianta).

Cur síos:

Is inhibitor FGFR2 gníomhach ó bhéal, dochúlaithe agus an-roghnach é Lirafugratinib (RLY-4008).

Sprioc: FGFR2